T. Rowe Price Associates’s Sana Biotechnology SANA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$598K	Sell	207,492 -558,995	-73%	-$2.2M	﹤0.01%	2368
2025 Q4	$3.12M	Buy	766,487 +620,370	+425%	+$2.78M	﹤0.01%	1568
2025 Q3	$519K	Sell	146,117 -2,411,708	-94%	-$8.72M	﹤0.01%	2339
2025 Q2	$6.98M	Sell	2,557,825 -96,313	-4%	-$199K	﹤0.01%	1197
2025 Q1	$4.46M	Sell	2,654,138 -454,479	-15%	-$1.27M	﹤0.01%	1284
2024 Q4	$5.07M	Buy	3,108,617 +219,498	+8%	+$655K	﹤0.01%	1289
2024 Q3	$12M	Sell	2,889,119 -228,877	-7%	-$1.2M	﹤0.01%	1106
2024 Q2	$17M	Sell	3,117,996 -577,463	-16%	-$4.6M	﹤0.01%	995
2024 Q1	$37M	Buy	3,695,459 +101,434	+3%	+$760K	﹤0.01%	806
2023 Q4	$14.7M	Sell	3,594,025 -3,432,116	-49%	-$12.6M	﹤0.01%	1021
2023 Q3	$27.2M	Buy	7,026,141 +1,902,713	+37%	+$10.2M	﹤0.01%	844
2023 Q2	$30.5M	Buy	5,123,428 +612,642	+14%	+$3.53M	﹤0.01%	831
2023 Q1	$14.8M	Buy	4,510,786 +246,294	+6%	+$984K	﹤0.01%	992
2022 Q4	$16.8M	Buy	4,264,492 +623,989	+17%	+$3.05M	﹤0.01%	959
2022 Q3	$21.8M	Buy	3,640,503 +748,922	+26%	+$5.4M	﹤0.01%	879
2022 Q2	$18.6M	Buy	2,891,581 +841,448	+41%	+$5.36M	﹤0.01%	1188
2022 Q1	$16.9M	Buy	2,050,133 +845,437	+70%	+$6.84M	﹤0.01%	1273
2021 Q4	$18.6M	Buy	1,204,696 +17,587	+1%	+$339K	﹤0.01%	1302
2021 Q3	$26.7M	Sell	1,187,109 -3,090	-0.3%	-$64.9K	﹤0.01%	1223
2021 Q2	$23.4M	Sell	1,190,199 -16,511	-1%	-$374K	﹤0.01%	1263
2021 Q1	$40.4M	Buy	+1,206,710	New	+$39.3M	﹤0.01%	1077